Browse Category

NASDAQ:LIMN News 3 February 2026

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

New York, Feb 3, 2026, 07:20 (EST) — Premarket Shares of Liminatus Pharma, Inc. (LIMN) jumped 29.4% to $0.74 during premarket trading Tuesday, on volume of roughly 5.3 million shares. The firm’s market cap stood near $15.5 million. (StockAnalysis) The stock surged 64.6% in after-hours trading Monday, climbing to $0.94 following the 4 p.m. close, after finishing the regular session…

Stock Market Today

  • iShares Core MSCI International Developed Markets ETF Sees $1.3 Billion Inflow Amid Varied Stock Movements
    February 3, 2026, 11:29 AM EST. The iShares Core MSCI International Developed Markets ETF (IDEV) recorded a significant $1.3 billion inflow, a 4.8% increase in units outstanding week over week. Despite gains in TEVA Pharmaceutical Industries Ltd (TEVA, +3.5%), major IDEV holdings like Spotify Technology SA (SPOT, -4.2%) and Sea Ltd (SE, -5.1%) slipped in today's trading. IDEV's share price approached its 52-week high at $87.03, near the peak of $87.96, while its low stood at $61.11. ETF unit creation boosts demand for underlying assets, influencing individual stock activity. Tracking these inflows provides insights into broader market trends within international developed markets exposure.
Go toTop